Conducting Clinical Trials Since 1988
Velocity Clinical Research, Cincinnati was founded by Dr. Gregory Gottschlich in 1988 as New Horizons Clinical Research, an independent dedicated research center. Dr. Gottschlich, who is Board Certified in Internal Medicine, established the research center to handle the growing need for clinical trials in his specialty. Velocity Cincinnati offers a wide range of expertise in Respiratory, Immunology, Internal medicine, Rheumatology and Orthopedic indications, including allergy, asthma, COPD, hypertension, CAD, hyperlipidemia, diabetes, osteoarthritis, musculoskeletal disorders, gout, and chronic pain. In addition, this site has experience conducting studies in vaccines and rare diseases.
Velocity Cincinnati has a large and diverse study participant population, including pediatric and geriatric patients from a range of ethnic backgrounds. An expansive patient database enhances recruitment efforts.
Located in Blue Ash, a suburb of Cincinnati, Ohio, just 15 minutes north of downtown Cincinnati and only 30 minutes from the Northern Kentucky/Cincinnati International Airport, this site has easy access to main highways. The building is just across the street from a large park and less than two miles from two area hospitals. Ample free parking is on site. With more than 7,200 square-feet of dedicated research space, they can efficiently and effectively conduct multiple concurrent studies.
The Velocity Cincinnati team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine though research. Dr. Gottschlich was instrumental in recognizing the need to join together geographically dispersed research sites and took leadership in achieving that goal. By becoming part of the Velocity Clinical Research organization in 2017, Cincinnati added new efficiencies and integration to their already comprehensive approaches to conducting clinical trials.